Janssen Cilag S.A.S.

Quick facts

Phase 3 pipeline

• Epo-alpha · Hematology/Oncology
  Epo-alpha is a recombinant erythropoietin that stimulates red blood cell production by binding to erythropoietin receptors on bone marrow progenitor cells.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Janssen Cilag S.A.S. portfolio CI brief
• Janssen Cilag S.A.S. pipeline updates RSS